Complementary Effects of Surgery and Pexidartinib in the Management of Patients with Complex Diffuse-Tenosynovial Giant Cell Tumor
Tenosynovial giant cell tumor (TGCT) is a rare neoplasm of the joint synovium that has a wide clinical spectrum including pain and stiffness in the affected joint, joint swelling, periarticular erosions, and cartilage loss, which can severely impact quality of life. The mainstay treatment for TGCT h...
Saved in:
| Main Authors: | Nicholas M. Bernthal, R. Lor Randall, Lauren N. Zeitlinger, Erik J. Geiger, John H. Healey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Orthopedics |
| Online Access: | http://dx.doi.org/10.1155/2022/7768764 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient-Reported Continued Benefits in Patients Treated with Pexidartinib for Tenosynovial Giant Cell Tumor Based on a Real-World Study in the United States
by: Margaret Wooddell PhD, MBA, et al.
Published: (2024-12-01) -
Treatment Choices for Tenosynovial Giant Cell Tumor: Surgery or Observation?
by: Hairong XU, et al.
Published: (2025-01-01) -
Results of the surgical treatment of diffuse pigmented villonodular synovitis (diffuse-type tenosynovial giant-cell tumor) of the knee
by: S. I. Herasymenko, et al.
Published: (2021-10-01) -
Diagnostic Challenge of Localized Tenosynovial Giant Cell Tumor in Children
by: Jiro Ichikawa, et al.
Published: (2025-01-01) -
Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: Clinical Course After Anterior Open Synovectomy
by: Alessandro Bruschi, et al.
Published: (2025-06-01)